Chemotherapy dose reduction due to chemotherapy induced peripheral neuropathy in breast cancer patients receiving chemotherapy in the neoadjuvant or adjuvant settings: a single-center experience

PURPOSE: Taxanes are a cornerstone treatment in early and advanced stage breast cancer and in other common solid tumor malignancies; however, the development of chemotherapy induced peripheral neuropathy (CIPN) often necessitates dose-reduction, which may hamper the effectiveness of the drug and com...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhatnagar, Bhavana, Gilmore, Steven, Goloubeva, Olga, Pelser, Colleen, Medeiros, Michelle, Chumsri, Saranya, Tkaczuk, Katherine, Edelman, Martin, Bao, Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4117856/
https://www.ncbi.nlm.nih.gov/pubmed/25089251
http://dx.doi.org/10.1186/2193-1801-3-366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4117856/
https://www.ncbi.nlm.nih.gov/pubmed/25089251
http://dx.doi.org/10.1186/2193-1801-3-366

Ejemplares similares